Squarepoint Ops LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$171,656
-81.9%
10,885
-67.5%
0.00%
-100.0%
Q1 2023$950,338
-6.6%
33,498
-3.8%
0.00%0.0%
Q4 2022$1,017,789
+61.0%
34,820
+45.6%
0.00%
+33.3%
Q3 2022$632,000
+71.7%
23,910
+188.8%
0.00%
+50.0%
Q2 2022$368,000
-21.5%
8,278
-12.6%
0.00%0.0%
Q1 2022$469,000
+9.6%
9,470
+12.7%
0.00%
+100.0%
Q4 2021$428,000
+92.8%
8,402
+61.7%
0.00%0.0%
Q2 2021$222,000
-43.1%
5,197
-38.0%
0.00%
-66.7%
Q4 2020$390,000
-31.1%
8,381
-37.1%
0.00%
-62.5%
Q3 2020$566,000
+124.6%
13,334
+153.6%
0.01%
+100.0%
Q2 2020$252,000
-67.0%
5,257
-68.3%
0.00%
-80.0%
Q1 2020$763,000
-61.0%
16,595
-49.0%
0.02%
+66.7%
Q4 2019$1,956,000
+341.5%
32,559
+315.4%
0.01%
+200.0%
Q3 2019$443,000
-70.1%
7,838
-70.5%
0.00%
-71.4%
Q2 2019$1,482,000
-14.2%
26,609
-22.2%
0.01%
-22.2%
Q1 2019$1,727,000
+12.2%
34,200
-10.4%
0.02%0.0%
Q4 2018$1,539,000
+515.6%
38,188
+704.5%
0.02%
+350.0%
Q1 2018$250,000
-91.1%
4,747
-90.9%
0.00%
-91.8%
Q4 2017$2,797,000
-23.6%
52,360
+12.8%
0.05%
-31.9%
Q2 2017$3,662,000
+61.8%
46,425
+70.1%
0.07%
+16.1%
Q1 2017$2,263,000
+260.4%
27,286
+204.2%
0.06%
+47.6%
Q3 2016$628,000
+38.3%
8,971
-23.3%
0.04%
+50.0%
Q2 2016$454,00011,7000.03%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders